Literature DB >> 7981617

Hepatocyte growth factor and its receptor, the tyrosine kinase encoded by the c-MET proto-oncogene.

E Vigna1, L Naldini, L Tamagnone, P Longati, A Bardelli, F Maina, C Ponzetto, P M Comoglio.   

Abstract

HGF is secreted by mesenchymal cells and regulates motogenesis, mitogenesis, and morphogenesis of epithelial and endothelial cells. HGF is a heterodimer of two glycosylated chains, alpha and beta, bound together by a disulfide bond. The molecule is synthesized as single chain precursor devoid of biological activity (pro-HGF). The critical step in pro-HGF activation is a proteolytic cleavage generating the two chain form. This step occurs in the extracellular environment, and is catalyzed by urokinase. Two alternative transcripts originate two HGF variants. One bears a deletion of five amino acids in the alpha chain, and has the same properties of the full-size protein. The other one contains only the first portion of the alpha chain (two kringle HGF). Two kringle HGF binds the HGF receptor, triggers its tyrosine kinase activity and behaves as a partial agonist, inducing motogenesis but not mitogenesis in target cells. The HGF receptor is the tyrosine kinase encoded by the c-MET pro-oncogene, a tyrosine kinase receptor. This molecule is an heterodimer of an extracellular alpha chain disulfide linked to a transmembrane beta chain. The cytoplasmic portion of the beta chain contains the catalytic domain and critical sites for the regulation of its kinase activity. In the C-terminal tail, a bidentate motif containing two tyrosines associates the transducers responsible for HGF signalling.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7981617

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  17 in total

1.  Proteolytic processing regulates receptor specificity and activity of VEGF-C.

Authors:  V Joukov; T Sorsa; V Kumar; M Jeltsch; L Claesson-Welsh; Y Cao; O Saksela; N Kalkkinen; K Alitalo
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

2.  Regulated expansion of human pancreatic beta-cells.

Authors:  Eszter Pais; Jean Park; Tamas Alexy; Vahagn Nikolian; Shundi Ge; Kit Shaw; Shantha Senadheera; Cinnamon L Hardee; Dianne Skelton; Roger Hollis; Gay M Crooks; Donald B Kohn
Journal:  Mol Ther       Date:  2010-04-13       Impact factor: 11.454

3.  NK1, a natural splice variant of hepatocyte growth factor/scatter factor, is a partial agonist in vivo.

Authors:  J L Jakubczak; W J LaRochelle; G Merlino
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

4.  SV40 replication in human mesothelial cells induces HGF/Met receptor activation: a model for viral-related carcinogenesis of human malignant mesothelioma.

Authors:  P Cacciotti; R Libener; P Betta; F Martini; C Porta; A Procopio; L Strizzi; L Penengo; M Tognon; L Mutti; G Gaudino
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

5.  Tyrosine residues 654 and 670 in beta-catenin are crucial in regulation of Met-beta-catenin interactions.

Authors:  Gang Zeng; Udayan Apte; Amanda Micsenyi; Aaron Bell; Satdarshan P S Monga
Journal:  Exp Cell Res       Date:  2006-08-10       Impact factor: 3.905

6.  Urokinase-type plasminogen activator mRNA is expressed in normal developing teeth and leads to abnormal incisor enamel in alpha MUPA transgenic mice.

Authors:  Ruth Miskin; Tamar Masos; Zipi Shoham; Lisa Williams-Simons
Journal:  Transgenic Res       Date:  2006-04       Impact factor: 2.788

7.  Mechanism of biological synergy between cellular Src and epidermal growth factor receptor.

Authors:  D A Tice; J S Biscardi; A L Nickles; S J Parsons
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

8.  M10, a caspase cleavage product of the hepatocyte growth factor receptor, interacts with Smad2 and demonstrates antifibrotic properties in vitro and in vivo.

Authors:  Ilia Atanelishvili; Yuichiro Shirai; Tanjina Akter; Taylor Buckner; Atsushi Noguchi; Richard M Silver; Galina S Bogatkevich
Journal:  Transl Res       Date:  2015-12-19       Impact factor: 7.012

9.  Characterization of the enhancing effect of protamine on the proliferative activity of hepatocyte growth factor in rat hepatocytes.

Authors:  Ke-Xin Liu; Yukio Kato; Kunio Matsumoto; Toshikazu Nakamura; Taiichi Kaku; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2009-01-06       Impact factor: 4.200

10.  Hepatic reconstruction from fetal porcine liver cells using a radial flow bioreactor.

Authors:  Yuji Ishii; Ryota Saito; Hideki Marushima; Ryusuke Ito; Taro Sakamoto; Katsuhiko Yanaga
Journal:  World J Gastroenterol       Date:  2008-05-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.